Star Fisheries

Constant Therapeutics LLC is a private biopharmaceutical company based in Cambridge, specializing in the development of peptide and small molecule drugs. The company is currently focused on advancing Mas receptor agonists, including their lead drug candidate, TXA127, for the treatment of COVID-19, CNS, and rare disorders. TXA127, a pharmaceutical formulation of the natural human peptide angiotensin-1-7 (Ang-1-7), represents the forefront of Constant Therapeutics' innovative approach to addressing critical medical needs through cutting-edge drug development. With a commitment to clinical excellence, the company aims to make significant advancements in the field of biopharmaceuticals. Generated from their website's infomation

Portal Instruments, based in Cambridge, MA, is a pioneering company that is revolutionizing the field of drug delivery with their needle-free technology. Their innovative platform offers a painless and anxiety-free experience for patients, eliminating the need for traditional needle injections. With a focus on high viscosity biologics, Portal Instruments' system administers medication through the skin in less than half a second, providing a transformed patient experience. Designed to be adaptable to various needs, Portal's needle-free drug delivery system can handle volumes up to 2.0 mL in just 0.6 seconds, accommodating a wide range of viscosities and applications. The platform also captures and reports injection data, offering valuable insights and promoting compliance. Although still in development and not currently available for sale or use, Portal Instruments' groundbreaking technology has the potential to reshape the future of biologic administration.Generated from the website